# A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).

> **NCT04100460** · NA · UNKNOWN · sponsor: **Comet Bio Inc.** · enrollment: 45 (estimated)

## Conditions studied

- Gastrointestinal Tolerance

## Interventions

- **DIETARY_SUPPLEMENT:** 7.25 grams of Arabinoxylan leaf fiber extract
- **DIETARY_SUPPLEMENT:** 14.5 grams of Arabinoxylan leaf fiber extract
- **DIETARY_SUPPLEMENT:** Control - No Arabinoxylan

## Key facts

- **NCT ID:** NCT04100460
- **Lead sponsor:** Comet Bio Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09
- **Primary completion:** 2020-03
- **Final completion:** 2020-05
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2019-09-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04100460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04100460, "A Double Blind Study on the Gastrointestinal Effects of Arabinoxylan (Leaf Fiber Extract).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04100460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*